沈竞康 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences

基本信息

浏览量：87

职业迁徙

个人简介

研究方向：
生物活性天然产物的结构修饰
基于优势结构、天然活性物质、骨架跃迁、药物信息学等药物化学新技术的靶向化合物库研究
基于结构生物学、药物结构片段的药物发现、结构优化、构效关系研究
获奖及荣誉：
曾获上海市科技进步二等奖

研究兴趣

论文共 250 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Figure 3 from MCL-1 Degradation Mediated by JNK Activation Via MEKK1/TAK1-MKK4 Contributes to Anticancer Activity of New Tubulin Inhibitor MT189

Wei Wang,Ying-Qing Wang,Tao Meng,Jun-Mei Yi,Xia-Juan Huan, Lan-Ping Ma,Lin-Jiang Tong,Yi Chen,Jian Ding,Jing-Kang Shen,Ze-Hong Miao

openalex（2023）

引用0浏览0引用

Materials and Methods from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Wei Zhou, Peng Fang,Dongan Yu, Hongyuan Ren,Meng You, Long Yin,Fei Mei,Huikai Zhu, Zhenzhen Wang, Hui Xu,Yuxia Cao, Xiaowei Sun, Xiaohong Xu, Jianjun Bi,Jin Wang,Lanping Ma,Xin Wang,Lin Chen,Yongliang Zhang,Xiaowei Cen,Xi Zhu,Liguang Lou,Datao Liu,Xiaoding Tan,Jinliang Yang,Tao Meng,Jingkang Shen

openalex（2023）

引用0浏览0引用

Supplementary Figure 2 from MCL-1 Degradation Mediated by JNK Activation Via MEKK1/TAK1-MKK4 Contributes to Anticancer Activity of New Tubulin Inhibitor MT189

Wei Wang,Ying-Qing Wang,Tao Meng,Jun-Mei Yi,Xia-Juan Huan,Lan-Ping Ma,Lin-Jiang Tong,Yi Chen,Jian Ding,Jing-Kang Shen,Ze-Hong Miao

openalex（2023）

引用0浏览0引用

Supplementary Materials and Methods; Tables S1-S4; Figures S1-S2 from Preclinical Evaluation of SCC244 (glumetinib), a Novel, Potent, and Highly Selective Inhibitor of C-Met in MET-dependent Cancer Models

Jing Ai,Yi Chen, Xia Peng,Yinchun Ji,Yong Xi,Yanyan Shen,Xinying Yang,Yi Su, Yiming Sun,Yinglei Gao,Yuchi Ma,Bing Xiong,Jingkang Shen,Jian Ding,Meiyu Geng

openalex（2023）

引用0浏览0引用

Supplementary Figure 1 from MCL-1 Degradation Mediated by JNK Activation Via MEKK1/TAK1-MKK4 Contributes to Anticancer Activity of New Tubulin Inhibitor MT189

Wei Wang,Ying-Qing Wang,Tao Meng,Jun-Mei Yi,Xia-Juan Huan, Lan-Ping Ma,Lin-Jiang Tong,Yi Chen,Jian Ding,Jing-Kang Shen,Ze-Hong Miao

openalex（2023）

引用0浏览0引用

Supplementary Figure 5 from MCL-1 Degradation Mediated by JNK Activation Via MEKK1/TAK1-MKK4 Contributes to Anticancer Activity of New Tubulin Inhibitor MT189

Wei Wang,Ying-Qing Wang,Tao Meng,Jun-Mei Yi,Xia-Juan Huan,Lan-Ping Ma,Lin-Jiang Tong,Yi Chen,Jian Ding,Jing-Kang Shen,Ze-Hong Miao

openalex（2023）

引用0浏览0引用

Supplementary Table S13 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Wei Zhou,Peng Fang,Dongan Yu, Hongyuan Ren,Meng You, Long Yin,Fei Mei,Huikai Zhu, Zhenzhen Wang, Hui Xu,Yuxia Cao, Xiaowei Sun, Xiaohong Xu, Jianjun Bi,Jin Wang,Lanping Ma,Xin Wang,Lin Chen, Yongliang Zhang,Xiaowei Cen,Xi Zhu,Liguang Lou,Datao Liu,Xiaoding Tan,Jinliang Yang,Tao Meng,Jingkang Shen

crossref（2023）

引用0浏览0引用

Advances in Medicinal Chemistry of Estrogen-related Receptor Alpha (errα) Inverse Agonists

Haibin Zhang,Yongli Du,Yong Zheng,Huiting Lv,Zhijia Yan,Ning Dong,Yaling Zhu,Jingkang Shen

Current Topics in Medicinal Chemistry（2023）

引用0浏览0WOS引用

Supplementary Figure 7 from MCL-1 Degradation Mediated by JNK Activation Via MEKK1/TAK1-MKK4 Contributes to Anticancer Activity of New Tubulin Inhibitor MT189

Wei Wang,Ying-Qing Wang,Tao Meng,Jun-Mei Yi,Xia-Juan Huan, Lan-Ping Ma,Lin-Jiang Tong,Yi Chen,Jian Ding,Jing-Kang Shen,Ze-Hong Miao

openalex（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

Jingkang Shen(沈竞康)

研究员

论文共 250 篇作者统计合作学者相似作者